These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
592 related articles for article (PubMed ID: 33494388)
1. Synergistic Effects of Milk-Derived Exosomes and Galactose on Melnik BC Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33494388 [TBL] [Abstract][Full Text] [Related]
2. Plasma exosomes impair microglial degradation of α-synuclein through V-ATPase subunit V1G1. Li Y; Wang Y; Kou L; Yin S; Chi X; Sun Y; Wu J; Jin Z; Zhou Q; Zou W; Wang T; Xia Y CNS Neurosci Ther; 2024 May; 30(5):e14738. PubMed ID: 38702933 [TBL] [Abstract][Full Text] [Related]
3. Microglia as modulators of exosomal alpha-synuclein transmission. Xia Y; Zhang G; Han C; Ma K; Guo X; Wan F; Kou L; Yin S; Liu L; Huang J; Xiong N; Wang T Cell Death Dis; 2019 Feb; 10(3):174. PubMed ID: 30787269 [TBL] [Abstract][Full Text] [Related]
4. Analysis of α-Synuclein in Exosomes. Tsunemi T; Ishiguro Y; Yoroisaka A; Hattori N Methods Mol Biol; 2021; 2322():41-45. PubMed ID: 34043190 [TBL] [Abstract][Full Text] [Related]
5. α-Synuclein impairs ferritinophagy in the retinal pigment epithelium: Implications for retinal iron dyshomeostasis in Parkinson's disease. Baksi S; Singh N Sci Rep; 2017 Oct; 7(1):12843. PubMed ID: 28993630 [TBL] [Abstract][Full Text] [Related]
6. The Overcrowded Crossroads: Mitochondria, Alpha-Synuclein, and the Endo-Lysosomal System Interaction in Parkinson's Disease. Lin KJ; Lin KL; Chen SD; Liou CW; Chuang YC; Lin HY; Lin TK Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31731450 [TBL] [Abstract][Full Text] [Related]
7. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease. Sharma N; Rao SP; Kalivendi SV Free Radic Biol Med; 2019 May; 135():28-37. PubMed ID: 30796974 [TBL] [Abstract][Full Text] [Related]
8. Exosome-mediated delivery of antisense oligonucleotides targeting α-synuclein ameliorates the pathology in a mouse model of Parkinson's disease. Yang J; Luo S; Zhang J; Yu T; Fu Z; Zheng Y; Xu X; Liu C; Fan M; Zhang Z Neurobiol Dis; 2021 Jan; 148():105218. PubMed ID: 33296726 [TBL] [Abstract][Full Text] [Related]
9. Activation of β-Glucocerebrosidase Reduces Pathological α-Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons. Mazzulli JR; Zunke F; Tsunemi T; Toker NJ; Jeon S; Burbulla LF; Patnaik S; Sidransky E; Marugan JJ; Sue CM; Krainc D J Neurosci; 2016 Jul; 36(29):7693-706. PubMed ID: 27445146 [TBL] [Abstract][Full Text] [Related]
10. Exosome release and neuropathology induced by α-synuclein: new insights into protective mechanisms of Drp1 inhibition. Fan RZ; Guo M; Luo S; Cui M; Tieu K Acta Neuropathol Commun; 2019 Nov; 7(1):184. PubMed ID: 31744532 [TBL] [Abstract][Full Text] [Related]
11. Parkinson's Disease Derived Exosomes Aggravate Neuropathology in SNCA*A53T Mice. Huang Y; Liu Z; Li N; Tian C; Yang H; Huo Y; Li Y; Zhang J; Yu Z Ann Neurol; 2022 Aug; 92(2):230-245. PubMed ID: 35596947 [TBL] [Abstract][Full Text] [Related]
12. The Parkinson's disease-associated protein α-synuclein inhibits hepatoma by exosome delivery. Hou TZ; Yang HM; Cheng YZ; Gu L; Zhang JN; Zhang H Mol Carcinog; 2023 Aug; 62(8):1163-1175. PubMed ID: 37144864 [TBL] [Abstract][Full Text] [Related]
13. Microglial exosomes facilitate α-synuclein transmission in Parkinson's disease. Guo M; Wang J; Zhao Y; Feng Y; Han S; Dong Q; Cui M; Tieu K Brain; 2020 May; 143(5):1476-1497. PubMed ID: 32355963 [TBL] [Abstract][Full Text] [Related]
14. Identification of a highly neurotoxic α-synuclein species inducing mitochondrial damage and mitophagy in Parkinson's disease. Grassi D; Howard S; Zhou M; Diaz-Perez N; Urban NT; Guerrero-Given D; Kamasawa N; Volpicelli-Daley LA; LoGrasso P; Lasmézas CI Proc Natl Acad Sci U S A; 2018 Mar; 115(11):E2634-E2643. PubMed ID: 29487216 [TBL] [Abstract][Full Text] [Related]
15. Exosomes from patients with Parkinson's disease are pathological in mice. Han C; Xiong N; Guo X; Huang J; Ma K; Liu L; Xia Y; Shen Y; Li J; Jiang H; Wang L; Guo S; Xu X; Zhang G; Liu J; Cao X; Zhang Z; Lin Z; Wang T J Mol Med (Berl); 2019 Sep; 97(9):1329-1344. PubMed ID: 31302715 [TBL] [Abstract][Full Text] [Related]
16. α-Synuclein mutation impairs processing of endomembrane compartments and promotes exocytosis and seeding of α-synuclein pathology. Stykel MG; Humphries KM; Kamski-Hennekam E; Buchner-Duby B; Porte-Trachsel N; Ryan T; Coackley CL; Bamm VV; Harauz G; Ryan SD Cell Rep; 2021 May; 35(6):109099. PubMed ID: 33979611 [TBL] [Abstract][Full Text] [Related]
17. Islet amyloid polypeptide triggers α-synuclein pathology in Parkinson's disease. Meng L; Li Y; Liu C; Zhang G; Chen J; Xiong M; Pan L; Zhang X; Chen G; Xiong J; Liu C; Xu X; Bu L; Zhang Z; Zhang Z Prog Neurobiol; 2023 Jul; 226():102462. PubMed ID: 37150314 [TBL] [Abstract][Full Text] [Related]
18. Environmental neurotoxicant manganese regulates exosome-mediated extracellular miRNAs in cell culture model of Parkinson's disease: Relevance to α-synuclein misfolding in metal neurotoxicity. Harischandra DS; Ghaisas S; Rokad D; Zamanian M; Jin H; Anantharam V; Kimber M; Kanthasamy A; Kanthasamy AG Neurotoxicology; 2018 Jan; 64():267-277. PubMed ID: 28450057 [TBL] [Abstract][Full Text] [Related]
19. Exosome Release Is Modulated by the Mitochondrial-Lysosomal Crosstalk in Parkinson's Disease Stress Conditions. Currim F; Singh J; Shinde A; Gohel D; Roy M; Singh K; Shukla S; Mane M; Vasiyani H; Singh R Mol Neurobiol; 2021 Apr; 58(4):1819-1833. PubMed ID: 33404982 [TBL] [Abstract][Full Text] [Related]